Blog
RSS FeedPosted by Michael Wonder on 31 Oct 2016
Otezla finally recommended for use by patients with psoriasis
25 October 2016 - Resubmission does better than initial submission. ...
Posted by Michael Wonder on 31 Oct 2016
CADTH recommends Epclusa
25 October 2016 - CADTH has recommended Gilead's new combination product for patients with chronic hepatitis C virus infection. ...
Posted by Michael Wonder on 30 Oct 2016
CADTH recommends the reimbursement of Taltz
25 October 2016 - The CADTH CDEC has recommend that ixekizumab be reimbursed for patients with moderate to severe plaque ...
Posted by Michael Wonder on 18 Oct 2016
CADTH calls for patient input on a submission for Zinbryta (daclizumab)
18 October 2016 - CADTH is calling for patient input on Biogen's submission for Zinbryta (daclizumab). ...
Posted by Michael Wonder on 17 Oct 2016
B.C. regulators plan to let pharmacists distribute abortion pills
17 October 2016 - The regulatory colleges that oversee doctors and pharmacists in British Columbia are planning to tell their ...
Posted by Michael Wonder on 12 Oct 2016
Ontario plans new treatment for opioid addiction
12 October 2016 - Ontario plans to treat patients addicted to opioids with a safer but more expensive pharmaceutical therapy ...
Posted by Michael Wonder on 12 Oct 2016
CADTH calls for patient input on submission from Servier for Corlovan
11 October - CADTH is calling for patient input on a submission from Servier for Corlovan (ivabradine hydrochloride). ...
Posted by Michael Wonder on 01 Oct 2016
CADTH publishes initial recommendation for Afinitor (everolimus)
29 September 2016 - CADTH has published its initial recommendtation for Novartis' Afinitor. ...
Posted by Michael Wonder on 27 Sep 2016
Why is getting the abortion pill to women such a complicated thing?
27 September 2016 - Already the victims of Health Canada’s glacial bureaucracy, and of its paternalistic view of their ability to ...
Posted by Michael Wonder on 26 Sep 2016
Most provincial drug plans won’t cover abortion pills in Canada
26 September 2016 - When the gold standard in medical abortion drugs finally becomes available in Canada later this year, the ...
Posted by Michael Wonder on 22 Sep 2016
CADTH calls for patient input on a resubmission from NovoNordisk for Victoza (liraglutide)
21 September 2016 - CADTH is calling for patient input on a resubmission from Novo Nordisk for Victoza (liraglutide). ...
Posted by Michael Wonder on 16 Sep 2016
CADTH drug portfolio information sessions
16 September 2016 - The CADTH Drug Portfolio Information Sessions are an opportunity for stakeholders to receive an update on the ...
Posted by Michael Wonder on 14 Sep 2016
CADTH update for patient groups
13 September 2016 - CADTH is inviting patient group comments and feedback on the proposed revisions to the patient input template ...
Posted by Michael Wonder on 13 Sep 2016
CADTH calls for patient input on submission from Sanofi for sarilumab
13 September 2016 - CADTH is calling for patient input on Sanofi Genzyme's new interleukin 6 receptor antagonist. ...
Posted by Michael Wonder on 11 Sep 2016
CADTH calls for patient input on submission from Duchesnay for Mictoryl (propiverine hydrochloride)
9 February 2016 - CADTH is seeking patient input on a submission from Duchesnay for Mictoryl. ...